cc.\*:("002B02F02")
Résultats 1 à 25 sur 7509
Sélection :
Landiolol: A Review of its use in Intraoperative and Postoperative TachyarrhythmiasPLOSKER, Greg L.Drugs (Basel). 2013, Vol 73, Num 9, pp 961-979, issn 0012-6667, 19 p.Article
Enhanced Repolarization Capacity: New Potential Antiarrhythmic Strategy Based on hERG Channel ActivationSZABO, G; FARKAS, V; GRUNNET, M et al.Current medicinal chemistry. 2011, Vol 18, Num 24, pp 3607-3621, issn 0929-8673, 15 p.Article
Postmortem Acidification of Blood/Organs Induces an Increase in Flecainide Concentration in Cardiac Blood and the Contribution of the Lungs to This IncreaseYOSHITOME, Kei; ISHIZU, Hideo; MIYAISHI, Satoru et al.Journal of analytical toxicology. 2010, Vol 34, Num 1, pp 26-31, issn 0146-4760, 6 p.Article
Three Questions for Evidence-Based Cardiac ElectrophysiologyKRAMER, Daniel B; JOSEPHSON, Mark E.Circulation. Cardiovascular quality and outcomes (Print). 2010, Vol 3, Num 6, pp 704-709, issn 1941-7713, 6 p.Article
Peptides Targeting Gap Junctional StructuresHERVE, Jean-Claude; DHEIN, Stefan.Current pharmaceutical design (Print). 2010, Vol 16, Num 28, pp 3056-3070, issn 1381-6128, 15 p.Article
Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agentsPIATNITSKI CHEKLER, Eugene L; BUTERA, John A; LI DI et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 16, pp 4551-4554, issn 0960-894X, 4 p.Article
Pharmacology of the short QT syndrome N588KhERG K+ channel mutation : differential impact on selected class I and class III antiarrhythmic drugsMCPATE, M. J; DUNCAN, R. S; HANCOX, J. C et al.British journal of pharmacology. 2008, Vol 155, Num 6, pp 957-966, issn 0007-1188, 10 p.Article
Thermodynamics of Partitioning of Propranolol in Some Organic Solvent/Buffer SystemsREYES, Andrea C; TRIANA, Maria T; JIMENEZ-KAIRUZ, Alvaro F et al.Journal of chemical and engineering data (Print). 2008, Vol 53, Num 12, pp 2810-2815, issn 0021-9568, 6 p.Article
Benzopyran sulfonamides as Kv1.5 potassium channel blockersLLOYD, John; ATWAL, Karnail S; JENKINS-WEST, Tonya et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 12, pp 3271-3275, issn 0960-894X, 5 p.Article
Propranolol preparations on the Belgian market : A comparative studyDE BRAEKELEER, K; FIERENS, C; CORTHOUT, J et al.Journal de pharmacie de Belgique. 2007, Vol 62, Num 3, pp 80-84, issn 0047-2166, 5 p.Article
Molecular regulation and pharmacology of pacemaker channelsBOIS, Patrick; GUINAMARD, Romain; CHEMALY, Antoun E. L et al.Current pharmaceutical design. 2007, Vol 13, Num 23, pp 2338-2349, issn 1381-6128, 12 p.Article
If inhibition by ivabradineBORER, Jeffrey S.Drugs (Basel). 2007, Vol 67, issn 0012-6667, 52 p., SUP2Serial Issue
Flécaïnide oral LP (Flécaïne LP) : l'évaluation n'a pas progressé = Oral long-acting flecainide : evaluationLa Revue Prescrire. 2006, Vol 26, Num 269, issn 0247-7750, p. 96Article
Pharmacological treatment of atrial fibrillation : Mechanisms of action and efficacy of class III drugsLOMBARDI, Federico; TERRANOVA, Paolo.Current medicinal chemistry. 2006, Vol 13, Num 14, pp 1635-1653, issn 0929-8673, 19 p.Article
Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillationTROTTER, B. Wesley; NANDA, Kausik K; WHITE, Rebecca B et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 24, pp 6954-6957, issn 0022-2623, 4 p.Article
Effect of the antifibrillatory compound tedisamil (KC-8857) on transmembrane currents in mammalian ventricular myocytesJOST, N; VIRAG, L; HALA, O et al.Current medicinal chemistry. 2004, Vol 11, Num 24, pp 3219-3228, issn 0929-8673, 10 p.Article
Pharmacokinetics-pharmacodynamics during drug development: An example from servier : IvabradineLAVEILLE, Christian; JOCHEMSEN, Roeline.Thérapie (Paris). 2004, Vol 59, Num 2, pp 173-177, issn 0040-5957, 5 p.Conference Paper
Essais cliniques des traitements β-bloquants dans l'insuffisance cardiaque : histoire, synthèse et perspectives = Clinical trials of β-blockers in heart failure: History, overview and future prospectsLECHAT, Philippe.Thérapie (Paris). 2004, Vol 59, Num 5, pp 517-526, issn 0040-5957, 10 p.Conference Paper
QT dispersion after beta-blocker therapy (Carvedilol or metoprolol) in children with heart failureETHERIDGE, Susan P; SHADDY, Robert E.The American journal of cardiology. 2003, Vol 91, Num 12, pp 1497-1500, issn 0002-9149, 4 p.Article
Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillationKHAN, Ijaz A; MEHTA, Nirav J; GOWDA, Ramesh M et al.International journal of cardiology. 2003, Vol 89, Num 2-3, pp 239-248, issn 0167-5273, 10 p.Article
Antiarrhythmic effect of magnesium sulfate after open heart surgery: effect of blood levelsKIZILTEPE, Ugursay; EYILETEN, Zeynep Bastuzel; SIRLAK, Mustafa et al.International journal of cardiology. 2003, Vol 89, Num 2-3, pp 153-158, issn 0167-5273, 6 p.Article
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodellingWORKMAN, Antony J; KANE, Kathleen A; RUSSELL, Julie A et al.Cardiovascular research. 2003, Vol 58, Num 3, pp 518-525, issn 0008-6363, 8 p.Article
Effectiveness of Amiodarone for conversion of atrial fibrillation to sinus rhythm: A meta-analysisLETELIER, Luz M; UDOL, Kamol; ENA, Javier et al.Archives of internal medicine (1960). 2003, Vol 163, Num 7, pp 777-785, issn 0003-9926, 9 p.Article
Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: Insights into the mechanism of the superior efficacy of amiodaroneSHINAGAWA, Kaori; SHIROSHITA-TAKESHITA, Akiko; SCHRAM, Gernot et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 10, pp 1440-1446, issn 0009-7322, 7 p.Article
Electrophysiologic characterization of dronedarone in guinea pig ventricular cellsGAUTIER, Patrick; GUILLEMARE, Eric; MARION, Aline et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 2, pp 191-202, issn 0160-2446, 12 p.Article